Yıl: 2021 Cilt: 43 Sayı: 6 Sayfa Aralığı: 530 - 536 Metin Dili: İngilizce DOI: 10.14744/etd.2021.33716 İndeks Tarihi: 18-02-2022

Clarifying Terminology of Signs in COVID-19

Öz:
The term “sign” has been used to describe various phenomena observed in patients with coronavirus disease 2019 (COVID-19). Discrepancies in the use of this term have been identified when it is used in context with COVID-19. The goals of this review are to provide an overview, describe signs, and clarify misconceptions regarding the use of these terms in COVID-19 patients. PubMed and Medline databases were searched using individual and Medical Subject Headings (MeSH) terms, including coronavirus, COVID-19, and sign, in human studies within the English literature published from inception to December 31, 2020. Studies where the word “sign” was used in a context different from that for COVID-19 (e.g., sentinel sign) were excluded. Three hundred fifty-seven studies were potentially identified and after applying the exclusion criteria and further adjudication, 92 studies constituted the final data set. The majority of signs found in the COVID-19 literature have been applied and aptly described primarily in radiologic diseases of the chest. The term “sign,” in other situations, is often misappropriated as it actually represents a physical finding rather than a sign. A total of 27 radiologic signs have been identified on chest computed tomography (CT) or high-resolution CT (HRCT), and 18 cutaneous signs (or findings) have been observed during the physical examination in COVID-19. Signs lack sufficient sensitivity or specificity by themselves; however, in the appropriate clinical setting, they should raise clinical suspicion for this infectious disease.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Diğer Erişim Türü: Erişime Açık
1
1
1
  • 1. Yale SH, Tekiner H, Mazza JJ, Yale ES. Confusing terminology in COVID-19: signs, symptoms, and physical findings. Erciyes Med J. February 15, 2021. doi: 10.14744/etd.2021.67434. [Epub aheadof-print].
  • 2. Nakano H, Kadowaki M, Furukawa T, Yoshida M. Rise in nocturnal respiratory rate during CPAP may be an early sign of COVID-19 in patients with obstructive sleep apnea. J Clin Sleep Med 2020; 16(10): 1811–3.
  • 3. Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323(13): 1239–42.
  • 4. Skinner HA. The Origin of Medical Terms. Baltimore: The Williams & Wilkins Company; 1949.
  • 5. Wilson JC. symptoms and signs. In: A Handbook of Medical Diagnosis: For the Use of Practitioners and Students. Philadelphia: JB Lippincott Company; 1911.p.389–98.
  • 6. Han R, Huang L, Jiang H, Dong J, Peng H, Zhang D. Early clinical and CT manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia. AJR Am J Roentgenol 2020; 215(2): 338–43.
  • 7. Johnstun J. A CT finding no longer zebra-specific. American Thoracic Society. 1998-2021. Available from: URL: https:// www.thoracic.org/ professionals/clinical-resources/critical-care/clinical- education/quickhits/a-ct-finding-no-longer-zebra-specific.php. Accessed Jan 21, 2021.
  • 8. Niang I, Fall MC, Diouf JCN, Thiam M, Diallo I, Faye I, et al. False ground-glass opacity and suspicion of COVID-19, beware of the technique for performing the CT. Pan Afr Med J 2020; 35(Suppl 2): 138.
  • 9. Lv H, Chen T, Pan Y, Wang H, Chen L, Lu Y. Pulmonary vascular enlargement on thoracic CT for diagnosis and differential diagnosis of COVID-19: a systematic review and meta-analysis. Ann Transl Med 2020; 8(14): 878.
  • 10. Marvisi M, Ferrozzi F, Balzarini L, Mancini C, Ramponi S, Uccelli M. First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: Factors predicting fibrotic evolution. Int J Infect Dis 2020; 99: 485–8.
  • 11. Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology 1985; 157(3): 611–4.
  • 12. Farias LPG, Pereira HAC, Anastacio EPZ, Minenelli FF, Teles GBDS. The halo sign as a chest computed tomography finding of COVID-19. Einstein (Sao Paulo) 2020; 18: eAI5742.
  • 13. Bekci T. “Reversed halo sign” on 3D CT in COVID-19. Diagn Interv Radiol 2020; 26(4): 379.
  • 14. Görkem SB, Çetin BŞ. COVID-19 pneumonia in a Turkish child presenting with abdominal complaints and reversed halo sign on thorax CT. Diagn Interv Radiol 2020; 26(6): 608–9.
  • 15. Marchiori E, Nobre LF, Hochhegger B, Zanetti G. The reversed halo sign: Considerations in the context of the COVID-19 pandemic. Thromb Res 2020; 195: 228–30.
  • 16. Sales AR, Casagrande EM, Hochhegger B, Zanetti G, Marchiori E. The reversed halo sign and COVID-19: Possible histopathological mechanisms related to the appearance of this imaging finding. Arch Bronconeumol 2021; 57 Suppl 1: 73–5.
  • 17. Aslan S. Multiple reversed halo sign on chest CT in COVID-19 pneumonia. Arch Bronconeumol 2021; 57(S1): 69.
  • 18. Farias LPG, Strabelli DG, Sawamura MVY. COVID-19 pneumonia and the reversed halo sign. J Bras Pneumol 2020; 46(2): e20200131.
  • 19. Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH, Chung M, et al. Radiological society of North America expert consensus statement on reporting chest CT findings related to COVID-19 endorsed by the society of thoracic radiology, the American College of Radiology, and RSNA. Radiol Cardiothorac Imaging 2020; 2(2): e200152.
  • 20. Poerio A, Sartoni M, Lazzari G, Valli M, Morsiani M, Zompatori M. Halo, reversed halo, or both? Atypical computed tomography manifestations of Coronavirus Disease (COVID-19) Pneumonia: The “Double Halo Sign”. Korean J Radiol 2020; 21(10): 1161–4.
  • 21. Müller CIS, Müller NL. Chest CT target sign in a couple with COVID-19 pneumonia. Radiol Bras 2020; 53(4): 252–4.
  • 22. McLaren TA, Gruden JF, Green DB. The bullseye sign: A variant of the reverse halo sign in COVID-19 pneumonia. Clin Imaging 2020; 68:191–6.
  • 23. Martins RR, Santana VG, Souza DL, Reinaux JCF. New CT finding (the target sign) in three patients with COVID-19 pneumonia. J Bras Pneumol 2020; 46(6): e20200413.
  • 24. Fu X, Li J, Huang Z, Xu Z, Yao W, Cui Y, et al. Dandelion clock-like sign on CT for diagnose of COVID-19. [Article in Chinese]. Nan Fang Yi Ke Da Xue Xue Bao 2020; 40(2): 159–63.
  • 25. Jin J, Gao DH, Mo X, Tan SP, Kou ZX, Chen YB, et al. Analysis of 4 imaging features in patients with COVID-19. BMC Med Imaging 2020; 20(1): 84.
  • 26. Ghosh S, Nandolia KK, Tale S, Mrudula K, Soibam PM, Vinay G. Reverse Batwing sign in COVID-19 pneumonia. QJM 2020; 113(11): 836.
  • 27. Gaensler EA, Carrington CB. Peripheral opacities in chronic eosinophilic pneumonia: the photographic negative of pulmonary edema. AJR Am J Roentgenol 1977; 128(1): 1–13.
  • 28. Liao JL, Chen Y, Huang CQ, He GQ, Du JC, Chen QL. Clinical differences in chest CT characteristics between the progression and remission stages of patients with COVID-19 pneumonia. Int J Clin Pract. 2020 Oct 17:e13760. doi: 10.1111/ijcp.13760. [Epub ahead of print].
  • 29. Adams HJA, Kwee TC, Yakar D, Hope MD, Kwee RM. Chest CT imaging signature of Coronavirus Disease 2019 infection: In pursuit of the scientific evidence. Chest 2020; 158(5): 1885–95.
  • 30. Bayramoglu Z, Canıpek E, Comert RG, Gasimli N, Kaba O, Sarı Yanartaş M, et al. Imaging Features of Pediatric COVID-19 on Chest Radiography and Chest CT: A Retrospective, Single-Center Study. Acad Radiol 2021; 28(1): 18–27.
  • 31. Çinkooğlu A, Hepdurgun C, Bayraktaroğlu S, Ceylan N, Savaş R. CT imaging features of COVID-19 pneumonia: initial experience from Turkey. Diagn Interv Radiol 2020; 26(4): 308–14.
  • 32. Qu J, Chang LK, Tang X, Du Y, Yang X, Liu X, et al. Clinical characteristics of COVID-19 and its comparison with influenza pneumonia. Acta Clin Belg 2020; 75(5): 348–56.
  • 33. Tan G, Lian X, Zhu Z, Wang Z, Huang F, Zhang Y, et al. Use of lung ultrasound to differentiate Coronavirus Disease 2019 (COVID-19) Pneumonia from community-acquired pneumonia. Ultrasound Med Biol 2020; 46(10): 2651–8.
  • 34. Caro-Dominguez P, Shelmerdine SC, Toso S, Secinaro A, Toma P, Damasio MB, et al; Collaborators of the European Society of Paediatric Radiology Cardiothoracic Task Force. Thoracic imaging of coronavirus disease 2019 (COVID-19) in children: a series of 91 cases. Pediatr Radiol 2020; 50(10): 1354–68.
  • 35. Wang K, Kang S, Tian R, Zhang X, Zhang X, Wang Y. Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area. Clin Radiol 2020; 75(5): 341–7.
  • 36. Wu R, Guan W, Gao Z, Wu N, Lv Y, Liu Y, et al. The arch bridge sign: a newly described CT feature of the coronavirus disease-19 (COVID-19) pneumonia. Quant Imaging Med Surg 2020; 10(7): 1551–8.
  • 37. Wang J, Xu Z, Wang J, Feng R, An Y, Ao W, et al. CT characteristics of patients infected with 2019 novel coronavirus: association with clinical type. Clin Radiol 2020; 75(6): 408–14.
  • 38. Li Q, Huang XT, Li CH, Liu D, Lv FJ. CT features of coronavirus disease 2019 (COVID-19) with an emphasis on the vascular enlargement pattern. Eur J Radiol 2021; 134: 109442.
  • 39. Shen C, Tan M, Song X, Zhang G, Liang J, Yu H, et al. Comparative Analysis of Early-Stage Clinical Features Between COVID-19 and Influenza A H1N1 Virus Pneumonia. Front Public Health 2020; 8: 206.
  • 40. Wu J, Pan J, Teng D, Xu X, Feng J, Chen YC. Interpretation of CT signs of 2019 novel coronavirus (COVID-19) pneumonia. Eur Radiol 2020; 30(10): 5455–62.
  • 41. Villanueva DH, Lusby HP, Islam SP, Gupte AA, Beatty NL. Heart failure exacerbation as only presenting sign of COVID-19. IDCases 2020; 21: e00870.
  • 42. Ye F, Hatahet M, Youniss MA, Toklu HZ, Mazza JJ, Yale S. The Clinical Significance of Relative Bradycardia. WMJ 2018; 117(2): 73–8.
  • 43. Ye F, Winchester D, Stalvey C, Jansen M, Lee A, Khuddus M, Mazza J, Yale S. Proposed mechanisms of relative bradycardia. Med Hypotheses 2018; 119: 63–7.
  • 44. Hiraiwa H, Goto Y, Nakamura G, Yasuda Y, Sakai Y, Kasugai D, et al. Relative bradycardia as a clinical feature in patients with coronavirus disease 2019 (COVID-19): A report of two cases. J Cardiol Cases 2020; 22(6): 260–4.
  • 45. Ikeuchi K, Saito M, Yamamoto S, Nagai H, Adachi E. Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, Japan. Emerg Infect Dis 2020; 26(10): 2504–6.
  • 46. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 2020; 77(6): 683–90.
  • 47. Méndez-Flores S, Zaladonis A, Valdes-Rodriguez R. COVID-19 and nail manifestation: be on the lookout for the red half-moon nail sign. Int J Dermatol 2020; 59(11): 1414.
  • 48. Neri I, Guglielmo A, Virdi A, Gaspari V, Starace M, Piraccini BM. The red half-moon nail sign: a novel manifestation of coronavirus infection. J Eur Acad Dermatol Venereol 2020; 34(11): e663–5.
  • 49. Wollina U, Karadağ AS, Rowland-Payne C, Chiriac A, Lotti T. Cutaneous signs in COVID-19 patients: A review. Dermatol Ther 2020; 33(5): e13549.
  • 50. Farabi B, Atak MF. Isolated maculopapular eruption localized to head and neck: A cutaneous sign of COVID-19 infection. Dermatol Ther 2020; 33(6): e14468.
  • 51. Wambier CG, Vaño-Galván S, McCoy J, Gomez-Zubiaur A, Herrera S, Hermosa-Gelbard Á, et al. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”. J Am Acad Dermatol 2020; 83(2): 680–2.
  • 52. Alamri A, Oriez C, Bouilloud F, Dupuy O, Ben Hamou A. Sudden onset anosmia and dysgeusia in two patients: An early sign of SARSCoV-2 infection. Presse Med 2020; 49(1): 104027.
  • 53. Jang Y, Son HJ, Lee S, Lee EJ, Kim TH, Park SY. Olfactory and taste disorder: The first and only sign in a patient with SARS-CoV-2 pneumonia. Infect Control Hosp Epidemiol 2020; 41(9): 1103.
  • 54. Kang YJ, Cho JH, Lee MH, Kim YJ, Park CS. The diagnostic value of detecting sudden smell loss among asymptomatic COVID-19 patients in early stage: The possible early sign of COVID-19. Auris Nasus Larynx 2020; 47(4): 565–73.
  • 55. Cruz Tapia RO, Peraza Labrador AJ, Guimaraes DM, Matos Valdez LH. Oral mucosal lesions in patients with SARS-CoV-2 infection. Report of four cases. Are they a true sign of COVID-19 disease?. Spec Care Dentist 2020; 40(6): 555–60.
  • 56. Ayatollahi P, Tarazi A, Wennberg R. Possible Autoimmune Encephalitis with Claustrum Sign in case of Acute SARS-CoV-2 Infection. Can J Neurol Sci. 2020 Sep 17:1-3. doi: 10.1017/cjn.2020.209. [Epub ahead of print].
  • 57. Zuhorn F, Omaimen H, Ruprecht B, Stellbrink C, Rauch M, Rogalewski A, et al. Parainfectious encephalitis in COVID-19: “The Claustrum Sign”. J Neurol. 2020 Sep 3:1–4. doi: 10.1007/s00415-020- 10185-y. [Epub ahead of print].
  • 58. Daruich A, Martin D, Bremond-Gignac D. Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): Interest of telemedicine during the pandemic context. J Fr Ophtalmol 2020; 43(5): 389–91.
  • 59. Scalinci SZ, Trovato Battagliola E. Conjunctivitis can be the only presenting sign and symptom of COVID-19. IDCases 2020; 20: e00774.
APA Yale S, Tekiner H, GORKEM S, Draves J, Ye F, Yale E (2021). Clarifying Terminology of Signs in COVID-19. , 530 - 536. 10.14744/etd.2021.33716
Chicago Yale Steven,Tekiner Halil,GORKEM SUREYYA BURCU,Draves Jacob,Ye Fan,Yale Eileen Clarifying Terminology of Signs in COVID-19. (2021): 530 - 536. 10.14744/etd.2021.33716
MLA Yale Steven,Tekiner Halil,GORKEM SUREYYA BURCU,Draves Jacob,Ye Fan,Yale Eileen Clarifying Terminology of Signs in COVID-19. , 2021, ss.530 - 536. 10.14744/etd.2021.33716
AMA Yale S,Tekiner H,GORKEM S,Draves J,Ye F,Yale E Clarifying Terminology of Signs in COVID-19. . 2021; 530 - 536. 10.14744/etd.2021.33716
Vancouver Yale S,Tekiner H,GORKEM S,Draves J,Ye F,Yale E Clarifying Terminology of Signs in COVID-19. . 2021; 530 - 536. 10.14744/etd.2021.33716
IEEE Yale S,Tekiner H,GORKEM S,Draves J,Ye F,Yale E "Clarifying Terminology of Signs in COVID-19." , ss.530 - 536, 2021. 10.14744/etd.2021.33716
ISNAD Yale, Steven vd. "Clarifying Terminology of Signs in COVID-19". (2021), 530-536. https://doi.org/10.14744/etd.2021.33716
APA Yale S, Tekiner H, GORKEM S, Draves J, Ye F, Yale E (2021). Clarifying Terminology of Signs in COVID-19. Erciyes Medical Journal, 43(6), 530 - 536. 10.14744/etd.2021.33716
Chicago Yale Steven,Tekiner Halil,GORKEM SUREYYA BURCU,Draves Jacob,Ye Fan,Yale Eileen Clarifying Terminology of Signs in COVID-19. Erciyes Medical Journal 43, no.6 (2021): 530 - 536. 10.14744/etd.2021.33716
MLA Yale Steven,Tekiner Halil,GORKEM SUREYYA BURCU,Draves Jacob,Ye Fan,Yale Eileen Clarifying Terminology of Signs in COVID-19. Erciyes Medical Journal, vol.43, no.6, 2021, ss.530 - 536. 10.14744/etd.2021.33716
AMA Yale S,Tekiner H,GORKEM S,Draves J,Ye F,Yale E Clarifying Terminology of Signs in COVID-19. Erciyes Medical Journal. 2021; 43(6): 530 - 536. 10.14744/etd.2021.33716
Vancouver Yale S,Tekiner H,GORKEM S,Draves J,Ye F,Yale E Clarifying Terminology of Signs in COVID-19. Erciyes Medical Journal. 2021; 43(6): 530 - 536. 10.14744/etd.2021.33716
IEEE Yale S,Tekiner H,GORKEM S,Draves J,Ye F,Yale E "Clarifying Terminology of Signs in COVID-19." Erciyes Medical Journal, 43, ss.530 - 536, 2021. 10.14744/etd.2021.33716
ISNAD Yale, Steven vd. "Clarifying Terminology of Signs in COVID-19". Erciyes Medical Journal 43/6 (2021), 530-536. https://doi.org/10.14744/etd.2021.33716